相关实验视频

Updated: Jul 19, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

前列腺特异性膜抗原:管理晚期前列腺癌的门户

Lena M Unterrainer1,2, Jeremie Calais1, Neil H Bander3,4

  • 1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA; email: lunterrainer@mednet.ucla.edu, jcalais@mednet.ucla.edu.

Annual review of medicine
|January 29, 2024
PubMed
概括

前列腺特异性膜抗原 (PSMA) 向治疗和成像,特别是使用放射性连接体,对晚期前列腺癌 (PC) 显示出显著的希望. 用PSMA向的放射性干疗法为转移性割抗性PC患者提供了改善的结果和生活质量.

关键词:
在这里,PET是PET.在PSMA成像中使用PSMA成像.抗体疗法是一种抗体疗法.定子发射断层扫描 (PET).精确瘤学 精确瘤学前列腺癌是前列腺癌.前列腺特异性膜抗原前列腺特异性膜抗原放射性合物治疗疗法

更多相关视频

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.8K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.1K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...